- Coordinator
- Assistance Publique Hopitaux De Paris, France
- Runs
- 1 November 2023 to 31 October 2028
- Status
- Running
- EU funding
- €6.3m
- Total cost
- €6.5m
- Partners
- 18 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101080964
What the project is doing
In the project's own words, from its summary on CORDIS.
Liver transplantation (LT) is a life-saving procedure for decompensated cirrhosis (DC) and hepato-cellular carcinoma (HCC). Its efficacy is hampered by the risk of death/drop-out on the Wait List (WL). This risk is driven by organ shortage and is mitigated by organ offering schemes. According to a sickest first policy, offering schemes prioritize LT candidates with the highest risk of dying, as assessed by predictive models.
To drive allocation, Organ Sharing Organizations (OSOs) use a 20-year-old model, the MELD, predicting mortality in DC but not in HCC. Because of a dramatic increase in % of HCC candidates (40% against 10% in early 20ties), MELD schemes are increasingly inaccurate, with persisting 15 to 30% mortality in countries with low/medium donation rate. This scenario, together with advances in prognosis in DC and HCC candidates and statistics, prompts LT community to look for up-dated algorithms to refine offering schemes.
To address this issue, key European LT stakeholders including OSOs, experts in LT, Statisticians, Research Labs and SME joined LEOPARD. Building on an innovative, harmonized OSOs pre-LT dataset and advances in modeling, LEOPARD propose to design and validate 1) an AI-based LEOPARD predictive algorithm outperforming current allocation models by better stratifying patients on the risk of mortality, to be proposed OSOs to drive allocation; 2) DC & HCC LEOPARD calculators available for professional for assistance in complex decision-making processes; 3) OMICs/radiomics predictive signatures integrated in a prototype 3rd-generation exploratory model.
We expect to generate computational tools improving candidates’ outcomes, with more patients transplanted on time. Adoption of these tools should result in harmonization of European heterogeneous prioritization schemes, and in a signification reduction in disparities of access to LT, a major objective pointed out by EC. LEOPARD should place Europe in leading position for organ offering schemes.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Assistance Publique Hopitaux De Paris | Paris | France | Coordinator |
| European Liver Patients Association | Bruxelles / Brussel | Belgium | Participant |
| European Association for the Studyof the Liver | Geneve | Switzerland | Associatedpartner |
| Universitatsklinikum Heidelberg | Heidelberg | Germany | Third party |
| European Foundation for the Study of Chronic Liver Failure (ef-Clif) | Barcelona | Spain | Participant |
| Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana | Valencia | Spain | Participant |
| Organizacion Nacional De Trasplantes | Madrid | Spain | Associatedpartner |
| Agence De La Biomedecine | Saint Denis La Plaine Cedex | France | Participant |
| Ecrin European Clinical Research Infrastructure Network | Paris | France | Participant |
| Epsa Innovation France | Issy-Les-Moulineaux | France | Participant |
| Fédération Nationale des Malades et Transplantés Hépatiques | Paris | France | Associatedpartner |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Universite Paris Cite | Paris | France | Associatedpartner |
| Istituto Superiore Di Sanita | Roma | Italy | Participant |
| Universite Du Luxembourg | Esch-Sur-Alzette | Luxembourg | Participant |
| European Society for Organ Transplantation | Amsterdam | Netherlands | Participant |
| Stichting Eurotransplant International Foundation | Leiden | Netherlands | Participant |
| Ophiomics - Investigacao E Desenvolvimento Em Biotecnologia SA | Lisboa | Portugal | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI